{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihmkprtbijhpxujzeldiwrcy7tmkrqdhrr5kmobdre6hnkvorfx6q",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mo7ex5ud6za2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihggaeg5giv3fcve6xmqll6eujucd2fhhkcx5mp3ncn6e3ivndvly"
    },
    "mimeType": "image/jpeg",
    "size": 827831
  },
  "path": "/news/2026-06-decreases-people-glp-medication.html",
  "publishedAt": "2026-06-13T18:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Adults with obesity who lost weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which is essential to protect muscle, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.",
  "title": "Study finds exercise decreases among people taking GLP-1 medication"
}